2020
DOI: 10.7759/cureus.10154
|View full text |Cite
|
Sign up to set email alerts
|

An Unusual Case of Moraxella osleonsis Bacteremia in an Immunocompetent Patient With SARS-CoV-2 Infection

Abstract: Moraxella osleonsis (M.osleonsis) is an organism that rarely presents with bacteremia in immunocompetent patients. We report a case of an immunocompetent 59-year-old male with a recent SARS-CoV-2 infection that developed M.osleonsis bacteremia. We believe that SARS-CoV-2 infection may have played a role in developing M.osleonsis bacteremia in this patient and may be one of the first reported cases of such bacteremia in a COVID-19 patient.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 20 publications
0
1
0
Order By: Relevance
“…Moraxella species apart from M. catarrhalis are extremely uncommon pathogens in human hosts, but case reports have described Moraxella species as unusual causes of invasive infections in humans, including septic arthritis, endocarditis, bacteremia, and meningitis (1)(2)(3)(4)(6)(7)(8)(9)(10)(11)(12)(13)(14). Risk factors for invasive disease secondary to Moraxella species may relate to comorbidities, immunocompromising conditions, injection drug use, and inherited and acquired complement deficiencies (1,4,8,15).…”
Section: Discussionmentioning
confidence: 99%
“…Moraxella species apart from M. catarrhalis are extremely uncommon pathogens in human hosts, but case reports have described Moraxella species as unusual causes of invasive infections in humans, including septic arthritis, endocarditis, bacteremia, and meningitis (1)(2)(3)(4)(6)(7)(8)(9)(10)(11)(12)(13)(14). Risk factors for invasive disease secondary to Moraxella species may relate to comorbidities, immunocompromising conditions, injection drug use, and inherited and acquired complement deficiencies (1,4,8,15).…”
Section: Discussionmentioning
confidence: 99%